PTPN11 and breast carcinoma: • Simultaneously inhibit CSF1R and SHP2 pathways• Repolarize M2 macrophages to M1 phenotype• Enhance phagocytic capabilities• Improve anti-cancer efficacy in aggressive 4T1 breast cancer mouse model